Should Investors Buy Marvell Stock Instead of Broadcom Stock?

Parkev Tatevosian, CFA•Aug 16, 2026

Summary

Parkev argues that Broadcom represents a better investment opportunity than Marvell Technology within the semiconductor industry. Parkev compares these two companies based on their revenue growth, operating profit margins, and return on invested capital, finding Broadcom superior in almost every metric. Parkev explains that both companies utilize an asset-light business model, focusing on design while outsourcing manufacturing to specialized firms.

AVGO: Parkev states that Broadcom's massive scale and 44% operating profit margin demonstrate its financial superiority over smaller competitors. Parkev calculates an intrinsic fair value of $488 for Broadcom using a discounted cash flow model, indicating it is undervalued compared to its $420 market price. Parkev further highlights that Broadcom offers a lower-risk profile with a beta of 1.22 and a more reasonable forward price-to-earnings ratio of 21.

MRVL: Parkev argues that Marvell Technology is currently overvalued, trading at a price of $225 compared to a calculated fair value of $181. Parkev notes that Marvell's forward price-to-earnings ratio of 36.3 is significantly higher than Broadcom's, despite Marvell having much lower operating margins at 16.4%. Parkev also points out the higher volatility associated with Marvell, which is reflected in its much higher beta of 2.28.

Mentioned Stocks

AVGO

Sentiment: BUYAction: RECOMMENDED

Reasoning: Parkev states that Broadcom is a superior pick because it has better operating margins of 44% and a robust ROIC of 20.34%. Parkev calculates a DCF intrinsic value of $488, which is well above the current market price of $420, making the stock appear meaningfully undervalued. Parkev also prefers Broadcom's lower forward P/E ratio of 21 and lower volatility compared to Marvell.

Loading chart...

MRVL

Sentiment: SELL

Reasoning: Parkev argues that Marvell Technology is overvalued at current market prices, with a DCF-calculated fair value of $181 compared to a price of $225. Parkev points out that Marvell trades at a more expensive forward P/E of 36.3 despite having lower profitability and higher risk, as indicated by its beta of 2.28. Parkev suggests the stock price is being inflated by investor enthusiasm rather than fundamental value.

Loading chart...